These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

556 related items for PubMed ID: 7536072

  • 61. Recovery of CFU-GM from cryopreserved marrow and in vivo evaluation after autologous bone marrow transplantation are predictive of engraftment.
    Douay L, Gorin NC, Mary JY, Lemarie E, Lopez M, Najman A, Stachowiak J, Giarratana MC, Baillou C, Salmon C.
    Exp Hematol; 1986 Jun; 14(5):358-65. PubMed ID: 3519263
    [Abstract] [Full Text] [Related]

  • 62. Comparison of autografting using mobilized peripheral blood stem cells with and without granulocyte colony-stimulating factor in malignant lymphomas.
    Brice P, Divine M, Marolleau JP, Haioun C, Dalcortivo L, Sitthy X, Beaujean F, Norol F, Benbunan M, Reyes F.
    Bone Marrow Transplant; 1994 Jul; 14(1):51-5. PubMed ID: 7524907
    [Abstract] [Full Text] [Related]

  • 63. Tolerance of sequential or simultaneous administration of IL-3 and G-CSF in improving peripheral blood stem cells harvesting following multi-agent chemotherapy: a pilot study.
    D'Hondt V, Guillaume T, Humblet Y, Doyen C, Chatelain B, Feyens AM, Staquet P, Osselaer JC, Müll B, Symann M.
    Bone Marrow Transplant; 1994 Mar; 13(3):261-4. PubMed ID: 7515299
    [Abstract] [Full Text] [Related]

  • 64. GM-CSF accelerates neutrophil recovery after autologous bone marrow transplantation for Hodgkin's disease.
    Devereaux S, Linch DC, Gribben JG, McMillan A, Patterson K, Goldstone AH.
    Bone Marrow Transplant; 1989 Jan; 4(1):49-54. PubMed ID: 2647187
    [Abstract] [Full Text] [Related]

  • 65. Factors influencing collection of peripheral blood stem cells in patients with multiple myeloma.
    Demirer T, Buckner CD, Gooley T, Appelbaum FR, Rowley S, Chauncey T, Lilleby K, Storb R, Bensinger WI.
    Bone Marrow Transplant; 1996 Jun; 17(6):937-41. PubMed ID: 8807097
    [Abstract] [Full Text] [Related]

  • 66. Hematologic recovery in patients who are treated with autologous stem cells transplantation taken from bone marrow after granulocyte-colony-stimulating factor stimulation.
    Gawronski K, Rzepecki P, Oborska S, Wasko-Grabowska A.
    Transplant Proc; 2011 Oct; 43(8):3114-5. PubMed ID: 21996240
    [Abstract] [Full Text] [Related]

  • 67. G-CSF is a major component of colony-stimulating activity (CSA) in the plasma of patients with multiple myeloma after treatment with high-dose melphalan (HDM).
    Joffe JK, Bell JB, Denham S, Adshead F, Millar JL, Millar BC.
    Exp Hematol; 1995 Apr; 23(4):376-82. PubMed ID: 7534716
    [Abstract] [Full Text] [Related]

  • 68. Hematopoietic growth factors for graft failure after bone marrow transplantation: a randomized trial of granulocyte-macrophage colony-stimulating factor (GM-CSF) versus sequential GM-CSF plus granulocyte-CSF.
    Weisdorf DJ, Verfaillie CM, Davies SM, Filipovich AH, Wagner JE, Miller JS, Burroughs J, Ramsay NK, Kersey JH, McGlave PB.
    Blood; 1995 Jun 15; 85(12):3452-6. PubMed ID: 7540062
    [Abstract] [Full Text] [Related]

  • 69. The efficacy of granulocyte colony-stimulating factor following autologous bone marrow transplantation for non-Hodgkin's lymphoma with monoclonal antibody purged bone marrow.
    Schriber JR, Negrin RS, Chao NJ, Long GD, Horning SJ, Blume KG.
    Leukemia; 1993 Oct 15; 7(10):1491-5. PubMed ID: 7692189
    [Abstract] [Full Text] [Related]

  • 70. Recombinant GM-CSF in patients with poor graft function after bone marrow transplantation.
    Klingemann HG, Eaves AC, Barnett MJ, Reece DE, Shepherd JD, Belch AR, Brandwein JM, Langleben A, Koch PA, Phillips GL.
    Clin Invest Med; 1990 Apr 15; 13(2):77-81. PubMed ID: 2191816
    [Abstract] [Full Text] [Related]

  • 71. Mobilization of hematopoietic progenitors from normal donors using the combination of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor results in fewer plasmacytoid dendritic cells in the graft and enhanced donor T cell engraftment with Th1 polarization: results from a randomized clinical trial.
    Lonial S, Akhtari M, Kaufman J, Torre C, Lechowicz MJ, Flowers C, Sinha R, Khoury HJ, Langston AA, Waller EK.
    Biol Blood Marrow Transplant; 2013 Mar 15; 19(3):460-7. PubMed ID: 23201472
    [Abstract] [Full Text] [Related]

  • 72. [Intensive chemotherapy with support of peripheral hematopoietic progenitor cells, mobilized with high-dose cyclophosphamide and G-CSF: fast hematologic recovery].
    Sola C, Mendoza L, Amill B, Mesía R, Rueda A, Alonso MC, Ojeda B, Artigas V, Tugues D, García J.
    Rev Clin Esp; 1995 Feb 15; 195(2):83-8. PubMed ID: 7732192
    [Abstract] [Full Text] [Related]

  • 73. Comparison of haematological recovery times and supportive care requirements of autologous recovery phase peripheral blood stem cell transplants, autologous bone marrow transplants and allogeneic bone marrow transplants.
    To LB, Roberts MM, Haylock DN, Dyson PG, Branford AL, Thorp D, Ho JQ, Dart GW, Horvath N, Davy ML.
    Bone Marrow Transplant; 1992 Apr 15; 9(4):277-84. PubMed ID: 1350938
    [Abstract] [Full Text] [Related]

  • 74. Delayed administration of granulocyte colony-stimulating factor after autologous bone marrow transplantation: effect on granulocyte recovery.
    Vey N, Molnar S, Faucher C, Le Corroller AG, Stoppa AM, Viens P, Bouabdallah R, Camerlo J, Novakovitch G, Mannoni P.
    Bone Marrow Transplant; 1994 Nov 15; 14(5):779-82. PubMed ID: 7534161
    [Abstract] [Full Text] [Related]

  • 75. Improvement of hematologic recovery after high-dose intensification using peripheral blood progenitor cells (PBPC) mobilized by chemotherapy and GM-CSF.
    Lamy T, Drenou B, Grulois I, Leberre C, Dauriac C, Amiot L, Godard M, Fauchet R, LePrise PY.
    Ann Hematol; 1994 Dec 15; 69(6):297-302. PubMed ID: 7993937
    [Abstract] [Full Text] [Related]

  • 76. Serum colony stimulating factors in patients undergoing bone marrow transplantation: enhancing effect of recombinant human GM-CSF.
    Geissler D, Niederwieser D, Aulitzky WE, Tilg H, Grünewald K, Huber C, Konwalinka G.
    Behring Inst Mitt; 1988 Aug 15; (83):289-300. PubMed ID: 3071343
    [Abstract] [Full Text] [Related]

  • 77. Recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF) shortens the period of neutropenia after autologous bone marrow transplantation in a primate model.
    Nienhuis AW, Donahue RE, Karlsson S, Clark SC, Agricola B, Antinoff N, Pierce JE, Turner P, Anderson WF, Nathan DG.
    J Clin Invest; 1987 Aug 15; 80(2):573-7. PubMed ID: 3301903
    [Abstract] [Full Text] [Related]

  • 78. The changing face of stem cell transplantation by the use of recombinant human granulocyte colony stimulating factor.
    Boogaerts MA, Demuynck H.
    Eur J Cancer; 1994 Aug 15; 30A Suppl 3():S34-9. PubMed ID: 7535071
    [Abstract] [Full Text] [Related]

  • 79. Relationship of infused CFU-GM and CFU-Mk mobilized by chemotherapy with or without G-CSF to platelet recovery after autologous blood stem cell transplantation.
    Takamatsu Y, Harada M, Teshima T, Makino S, Inaba S, Akashi K, Shibuya T, Niho Y.
    Exp Hematol; 1995 Jan 15; 23(1):8-13. PubMed ID: 7527786
    [Abstract] [Full Text] [Related]

  • 80. Recombinant human granulocyte-macrophage colony stimulating factor (rh GM-CSF) after bone marrow transplantation.
    Link H, Freund M, Kirchner H, Stoll M, Schmid H, Bucsky P, Seidel J, Schulz G, Schmidt RE, Riehm H.
    Behring Inst Mitt; 1988 Aug 15; (83):313-9. PubMed ID: 3071346
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 28.